immunosuppression

Documents about immunosuppression

• (TNX-1500) in Kidney Transplant Recipients#904531ClinicalTrials.gov
• Once Daily Immunosuppression Regimen#869818ClinicalTrials.gov
• Safety Outcomes of Lower Immunosuppression Versus Traditional Immunosuppression in Heart Transplant Recipients#903586ClinicalTrials.gov
• TRU-IMMUNO: Optimizing Liver Immunosuppression#866295ClinicalTrials.gov
• Effect of Immunosuppression in IgA Nephropathy#1171881ClinicalTrials.gov
• Study to Evaluate the Efficacy of Immunosuppression in Myocarditis or Inflammatory Cardiomyopathy.#1378780ClinicalTrials.gov
• Immunosuppression in Amyotrophic Lateral Sclerosis (ALS)#862347ClinicalTrials.gov
• Immune Response to Vaccination in Patients Receiving Single Drug Immunosuppression#909534ClinicalTrials.gov
• Immunosuppression Optimization Using The Prospera Assay In Kidney Transplant Recipients (IMPAKT)#878653ClinicalTrials.gov
• Viral Load Guided Immunosuppression After Lung Transplantation#1439021ClinicalTrials.gov
• Immunosuppression in HIV-infected Patients With Tuberculosis in Ethiopia#1465344ClinicalTrials.gov
• Effect of Immunosuppression Drug Weaning on Hepatitis C Virus (HCV)-Induced Liver Damage After Liver Transplantation#1280362ClinicalTrials.gov
• Monitoring of Corticosteroids Induced Immunosuppression Using Monocyte Human Leukocyte Antigen-DR (mHLA-DR).#1379165ClinicalTrials.gov
• Use of DNA Testing and Gene Expression Profiling to Help Transition Kidney Transplant Recipients to Belatacept-only Immunosuppression#839953ClinicalTrials.gov
• Pancreatic Islet Transplantation Into the Anterior Chamber of the Eye#1371626ClinicalTrials.gov
• Safety of Immunosuppression Minimization in Children and Adolescents After Kidney Transplantation#160215ClinicalTrials.gov
• Immunosuppression Management in Renal Transplant Recipients With Transplant Excellence Based on TruGraf Test#867467ClinicalTrials.gov
• Impact of Immunosuppression Adjustment on COVID-19 Vaccination Response in Kidney Transplant Recipients#993726ClinicalTrials.gov
• Use of DNA Testing to Help Transition Kidney Transplant Recipients to Belatacept-only Immunosuppression#1496571ClinicalTrials.gov
• Thymoglobulin Induction Therapy With Minimal Immunosuppression and Evaluation of Allograft Status#802751ClinicalTrials.gov
• Study on the Role of Gamma Delta T Cells in Sepsis Immunosuppression and Its Molecular Mechanism#1410228ClinicalTrials.gov
• Minimizing Immunosuppression in Old for Old Kidney Transplantation#849833ClinicalTrials.gov
• Comparative Efficacy of Mizoribine With Mycophenolate Mofetil for Living Related Kidney Transplantation Recipients#853225ClinicalTrials.gov
• The Role of ImmuKnow® in the Management of Immunosuppressants in the Renal Transplant Patient#893726ClinicalTrials.gov
• Evaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration (IMMUNOSEPSIS)#992260ClinicalTrials.gov
• Peripheral Immunologic Response of Solid Organ Transplant Recipients to Depletion Versus Non-depletion Protocols#1499017ClinicalTrials.gov
• Torque Teno Virus: A Biomarker of Immunosuppression#864452ClinicalTrials.gov
• Blood-Bile Ratio Tacrolimus After Liver Transplantation#898908ClinicalTrials.gov
• Tacrolimus Versus Cyclosporine for Immunosuppression After Lung Transplantation#842141ClinicalTrials.gov
• Plasma Levels of Danger-Associated Molecular Patterns in Young Children After Cardiac Surgery Under Cardiopulmonary Bypass#908987ClinicalTrials.gov
• The Effects of Microbiota Composition on Immunosuppression Protocols in Transplantation#1007054ClinicalTrials.gov
• Extracorporeal Photopheresis in Liver Transplantation. Phase II Clinical Trial in Safety and Efficacy in Patients With Gradual Decrease of Immunosuppression.#874547ClinicalTrials.gov
• Examination of Immunosuppression Adjustment Impact on Kidney Function in Liver Transplant#1127515ClinicalTrials.gov
• Tolerance Through Mixed Chimerism (Sip-Tego)#968605ClinicalTrials.gov
• Influenza Vaccination in Immunocompromized Patients#435803ClinicalTrials.gov
• Protective Immunity Project 01#804425ClinicalTrials.gov
• A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Kidney Transplant Patients#1352191ClinicalTrials.gov
• A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Liver Transplant Patients#1463533ClinicalTrials.gov
• HeartCare Immuno-optimization in Cardiac Allografts (MOSAIC)#1261596ClinicalTrials.gov
• First in Human Trial to Assess the Feasibility and Preliminary Safety of Adjunctive Treatment with the HemoSystem REBOOT in Critically Ill Patients with Sepsis-induced Immunosuppression#1307048ClinicalTrials.gov
• Mycophenolate Mofetil Immunosuppression Without/With Reduced Dose Calcineurin Inhibitor Long After Liver Transplantation#1442612ClinicalTrials.gov
• Immunosuppression and COVID-19 Boosters#846697ClinicalTrials.gov
• Drug Interaction Study With Rosuvastatin#1029766ClinicalTrials.gov
• Low Dose Sirolimus or CsA-Based Maintenance Immunosuppression After Induction With Campath-1 in Kidney Transplantation#1093079ClinicalTrials.gov
• Vaccination in systemic lupus erythematosus#205415Europe PMC
• Comparative Analysis of Anti-COVID-19 (Severe Acute Respiratory Syndrome) Humoral and Memory T Cell Responses in Children With Various Degrees of Immunosuppression:#802286ClinicalTrials.gov
• KidneyCare Immuno-optimization in Renal Allografts (KIRA)#1323163ClinicalTrials.gov
• Immunosuppression and Intensive Care Unit-acquired Multidrug-resistant Bacteria#398344ClinicalTrials.gov
• Envarsus XL Immunosuppression Following Liver Transplantation#901499ClinicalTrials.gov
• Belatacept in Liver Transplant Recipients#910455ClinicalTrials.gov